Capri Holdings Limited , a global fashion luxury group, today announced its financial results for the second quarter of Fiscal 2026 ended September 27, 2025. Second Quarter Fiscal 2026 Highlights from ...
Delivered Q3 2025 revenue of $83 million Q3 2025 non-dermatologic revenue increased by 67% over Q3 2024 Q3 2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, TissueCypher®) ...
CLN-049 demonstrated anti-leukemic activity, including multiple complete responses, in a heavily pretreated population of patients with r/r AML, regardless of FLT3 mutational status ...
કેટલાક પરિણામો છુપાયેલા છે કારણ કે તે તમારા માટે ઇનઍક્સેસિબલ હોઈ શકે છે.
ઇનઍક્સેસિબલ પરિણામો બતાવો
પ્રતિક્રિયા